Furthermore, Sharma and Singh reported that PPARγ is involved in FSH and PI3K signaling pathways for developing polycystic ovarian syndrome in response to rosiglitazone, an insulin sensitizer [78]. This evidence concerns the gene BRD2 and polycystic ovary syndrome.